Hungarian drugmaker Egis expects revenues to rise 4 to 6 percent at constant currencies in the year to October 2013 as strong growth in the Commonwealth of Independent States and Russia offsets falling sales at home.
"It is hard to predict revenue growth for next [fiscal] year in forints because you would have to have the philosopher's stone to know where the exchange rates will be, but on a constant currency basis we expect 4 percent to 6 percent expansion [to be] reachable," chief financial officer Csaba Poroszlai said at a news conference Tuesday.
On Monday, Egis posted a 121 percent rise in quarterly net profit year on year as rising exports offset a fall in domestic revenues following regulatory changes.
(Reuters)
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
